PMID: 374755May 1, 1979Paper

Malignancy in uremia: dialysis versus transplantation

The Journal of Urology
H W HerrJ Hostetler

Abstract

The incidence of cancer was compared in 499 dialysis patients and 121 renal transplant recipients. De novo malignancy developed in 15 patients on chronic dialysis (3 per cent) and in 6 transplant recipients (4.9 per cent), a significant increase over the expected number in the age-matched general population. There was no difference in the incidence of cancer in uremic patients on dialysis or after transplantation. A total of 10 dialysis patients (67 per cent) and 1 transplant patient (16 per cent) died of cancer. Neoplasms in the dialysis patients were the common types of mesenchymal tumors, while superficial skin cancers were seen more frequently in the transplant recipients. The differences in tumor types accounted for the higher mortality rate from cancer in the dialysis patients and may reflect different patterns of immunosuppression in these 2 patient populations.

References

Apr 19, 1975·Lancet·A J MatasJ S Najarian
Jan 1, 1977·Nephron·G A SutherlandR Gabriel
Jul 14, 1973·Lancet·R Hoover, J F Fraumeni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
R NaC M Vajdic
Lijec̆nic̆ki vjesnik
Lidija OrlićSanjin Racki
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
P AseniD Forti
© 2021 Meta ULC. All rights reserved